Navigation Links
Quorum IRB Board Chair to Speak at South Korean Research Summit
Date:9/17/2013

Quorum Review IRB

Quorum Review is an independent review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the United States and internationally, a specialized Phase I team, and unique processes for post-approval and registry studies.

Contact

Arri Burgess
Director, Client Relations & Marketing
Quorum Review IRB
(206) 436-3244
aburgess(at)quorumreview(dot)com

Read the full story at http://www.prweb.com/releases/2013/9/prweb11115823.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Quorum Review IRB Board Chair Appointed to SACHRP
2. Quorum Review IRB and ConsentSolutions Form Strategic Alliance
3. Quorum Review’s Mitchell Parrish Presents at Embracing Change: Clinical Research in the 21st Century
4. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
5. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
6. GenturaDx Announces Formation of Scientific Advisory Board
7. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
8. DiaTech Life Sciences Announces Medical Advisory Board
9. BioStorage Technologies Appoints New Member to Board of Directors
10. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
11. Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015 RXi Pharmaceuticals Corporation ... discovering and developing innovative therapeutics, primarily in the areas ... a public offering of 26 million units at a ... gross proceeds of approximately $10.4 million. Each unit consists ... 13-month overallotment purchase right to purchase 0.50 of a ...
(Date:5/28/2015)... Glenn Keet, CEO of Clinovo ... EMR/EHR Clinical Data Integration with EDC Systems ” at ... DC on June 14th-18th. , During the presentation, Glenn ... with EDC, and will examine the value of patient ... electronic health records/electronic medical records integration. , The ...
(Date:5/28/2015)... 28, 2015 In two different ... Sherley, M.D., Ph.D., will present the company’s unique approach ... a conference talk, he will describe Asymmetrex ’s ... with computer simulation to produce the first-ever technology for ... quality over time in culture. When leading an ...
(Date:5/27/2015)... , May 26, 2015 Research and ... the "Global Breast Cancer Monoclonal Antibodies Market ... Globally, Roche seems to dominate the breast ... Its block buster molecule, Herceptin has been able ... was found that breast cancer cells become recalcitrant ...
Breaking Biology Technology:RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants 3Clinovo Presents at the DIA 2015 51st Annual Meeting in Washington, DC on June 14th-18th 2Asymmetrex Will Discuss the Importance of Adult Tissue Stem Cell Time with 3D Tissue Engineers at the 14th Annual World Preclinical Congress in Boston in June 2Asymmetrex Will Discuss the Importance of Adult Tissue Stem Cell Time with 3D Tissue Engineers at the 14th Annual World Preclinical Congress in Boston in June 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3
... is launched at the Cellulosic Ethanol Summit in ... ... N.Y., Oct. 15 Genencor, a division of,Danisco A/S, today ... biomass enzyme developed specifically for,second generation biorefineries. Accellerase(TM) 1000 contains ...
... China Biopharma,Inc. (OTC Bulletin Board: CBPC) announced ... Co., Ltd. ("Soonfast") has successfully,completed its trial production ... been approved in China for external use to ... Tests have shown,an inhibitory effect on the growth ...
... - Neptune Technologies &,Bioressources Inc. ("Neptune") (NASDAQ.NEPT ... of a dynamic new Scientific Advisory Board ... Neptune believes that the combined knowledge ... Advisory Board will significantly contribute to Neptune,s,scientifically ...
Cached Biology Technology:Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol 2Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol 3Company's Partner Completes Trial Production of a New Antiviral Medicine 2Company's Partner Completes Trial Production of a New Antiviral Medicine 3Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board 2Neptune strengthens scientific operations with the appointment of a new Scientific Advisory Board 3
(Date:5/22/2015)... May 22, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... will be ending its promotional pricing and making the Wocket ... Laurence Savin , Head of Marketing said, "We,ve extended ... until the end of May. To get your wocket at ... we open the store on June 1, you,ll receive a ...
(Date:5/20/2015)... DUBLIN , May 20, 2015 ... Markets ( http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the ... of the Global Iris Recognition Market" ... http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service analyses ... across the government and commercial sectors, ...
(Date:5/19/2015)... 19, 2015 Research ... addition of the  "Genetic Testing Market Outlook ... http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic Testing ... of the current and future genetic testing ... their working principles and types are covered ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
... are abdominal obesity and high levels of a type of ... a person,s risk for stroke. The potential complications are serious: ... kidney disease and stroke. Preserving the ... a type of poly-unsaturated fat thought to play an important ...
... , A variation in the gene FOXO3A has ... is found much more often in people living to 100 ... A research group in the Faculty of Medicine at the ... comparing DNA samples taken from 388 German centenarians with those ...
... 2, 2009) -- By using OP9-DL1 ... the differentiation of embryonic stem cells into mature ... issue of Cold Spring Harbor Protocols ... from Juan Carlos Ziga-Pflcker,s laboratory at the University ...
Cached Biology News:Fighting obesity and illness with a novel approach to nutrition 2Fighting obesity and illness with a novel approach to nutrition 3Living longer thanks to the 'longevity gene' 2Cold Spring Harbor Protocols features stem cell differentiation, plant RNAi methods 2
Mouse polyclonal antibody raised against a partial recombinant TSEN2. NCBI Entrez Gene ID = 80746...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
... antibody raised against a partial ... Immunogen: SF3B2 (NP_006833, 592 ... recombinant protein with GST tag. ... NM_006842 ...
...
Biology Products: